- NeuroMab™ Anti-TNFα BBB Shuttle Antibody,Clone NR3088P (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- NeuroMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- NeuroMab™ Anti-Alpha Synuclein Antibody,Clone NR3861P (Cat#: NRP-0422-P614)
- NeuroMab™ Anti-TREM2 Antibody, Clone NR65P (Cat#: NRP-0422-P792)
- NeuroMab™ Anti-Tau Antibody,Clone NR1808P (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-FGFR1 Antibody,Clone NR3547P (Cat#: NRP-0422-P1244)
- NeuroMab™ Anti-Tau Antibody,Clone NR3320P (Cat#: NRP-0422-P1760)
- NeuroMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Mouse Hippocampal Neuron Cell HT22 (Cat#: NCL2110P001)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Glioblastoma Cell Line SF126 (Cat#: NCL-2108P35)
- Human CMEC/D3 Cell Line, Blood-Brain Barrier Model (Cat#: NCL-2108-P020)
- iNeu™ Microglia (Cat#: NCL-7P018)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit, TTF Assay (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- AAV2/2Retro-CAG-DIO-EGFP-2A-TetTox-pA [Neural Tracing] (Cat#: NTA-2012-ZP303)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- Dextran-CYanine5.5 (Cat#: NTA-2011-ZP118)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-EPO BBB Shuttle Protein, HIRMab-EPO (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein, cTfRMAb-GDNF (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein, HIRMab-IDUA (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein, cTfRMAb-IDUA (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein, HIRMab-GDNF (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein, cTfRMAb-TNFR (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein, HIRMab-ASA (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein, HIRMab-NAGLU (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein, HIRMab-PON1 (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein, cTfRMAb-EPO (Cat#: NRZP-0423-ZP499)
Fragile X Syndrome In Vitro Assay
Fragile X Syndrome (FXS) is a genetic disorder characterized by intellectual disabilities, behavioral challenges, and physical features. As a leading expert in the field of neuroscience, Creative Biolabs is committed to providing innovative solutions for studying and understanding FXS. Our state-of-the-art In Vitro assays offer a powerful platform to investigate the underlying molecular mechanisms of this disorder, enabling advancements in therapeutic development and personalized medicine.
Our Fragile X Syndrome Assay Models
At Creative Biolabs, we harness the power of induced pluripotent stem cells (iPSCs) derived from patients carrying an FMR1 mutation to faithfully replicate the pathophysiology of Fragile X syndrome. This innovative model allows researchers to delve into the intricate molecular and cellular intricacies of the disease, thereby gaining valuable insights. Furthermore, we also offer control cell lines without the mutation for comparative analysis.
Our Fragile X Syndrome Assays
To comprehensively assess the effects of potential therapeutics and understand the molecular mechanisms underlying Fragile X syndrome, it is essential to employ reliable and sensitive readout systems in In Vitro assays. Creative Biolabs offers a wide range of readout options that enable researchers to obtain accurate and quantitative data.
- Dendritic spine morphology analysis. Fragile X syndrome is characterized by abnormal dendritic spine development, and assessing changes in spine density and morphology can provide insights into the impact of potential therapeutic interventions on neuronal connectivity.
- Synaptic plasticity analysis: A key cellular process affected in Fragile X syndrome, can be evaluated using electrophysiological techniques such as patch-clamp recordings. This allows researchers to investigate alterations in synaptic transmission and excitability, providing valuable information about the functional consequences of Fragile X syndrome and the efficacy of potential therapeutic strategies.
Workflow of Fragile X Syndrome In Vitro Assay
At Creative Biolabs, we have developed a streamlined workflow for Fragile X syndrome In Vitro assays to ensure accurate and efficient experimental procedures. Our workflow includes the following key steps:
Highlight
![Cutting-edge Technologies](static/img/fragile-x-syndrome-in-vitro-assay-1.jpg)
Cutting-edge Technologies
![Customizability](static/img/fragile-x-syndrome-in-vitro-assay-2.jpg)
Customizability
![Expertise and Experience](static/img/fragile-x-syndrome-in-vitro-assay-3.jpg)
Expertise and Experience
Options for Collaborating with Creative Biolabs
-
Order Fragile X Syndrome assay models for use in your lab
If you are interested in ordering Fragile X Syndrome assay models and perform the assay in your lab, we offer a convenient and flexible supply of Fragile X Syndrome research cell models. Please contact info@creative-biolabs.org for availability and price information. -
Outsource your experiments to us
We offer a dependable and efficient service that involves collaborative experiment design to meet your specific needs. Please contact us today to explore the possibilities of collaborating with our organization.
Cat. | Product Name |
NCL-0723-ZP10 | Human iPSC-Derived Neural Stem Cells - Fragile X Syndrome Patient, FMR1 Mutation |
NCL-0723-ZP11 | Human iPSC-Derived Neural Stem Cells - Fragile X Syndrome Patient |
NCL-0723-ZP12 | Human iPSC-Derived Neural Stem Cells - Healthy |